KALVISTA PHARMACEUTICALS INC share price logo

KALVISTA PHARMACEUTICALS INC

Quote: KALV

$27.00

+0.01

(+0.04%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 10 Jun 2026

KALVISTA PHARMACEUTICALS INC Stock Performance

as on June 11, 2026 at 2:16 pm IST

  • Day's Low

    $26.98
    $27.00
    downward going graph

    0.07%

    Downside

  • 52 Week's Low

    $10.41
    $27.00
    downward going graph

    61.44%

    Downside

KALVISTA PHARMACEUTICALS INC share price movements today

Previous Close
$26.99
Open
$27.00
Volume
1.5M
Day's Low - High
$26.98 - $27.00
52 Week Low - High
$10.41 - $27.00

KALVISTA PHARMACEUTICALS INC Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

KALVISTA PHARMACEUTICALS INC Stock Fundamentals & Key Indicators

Check KALVISTA PHARMACEUTICALS INC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

KALVISTA PHARMACEUTICALS INC vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of KALVISTA PHARMACEUTICALS INC with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
KALVISTA PHARMACEUTICALS INC image
KALVISTA PHARMACEUTICALS INC
Buy$-NANA0.00%0.00%
Alnylam Pharma image
Alnylam Pharma
StrongBuy$22.1B-1.58%8.1077.28%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$141.7B208.09%32.2786.04%0.00%
Regeneron image
Regeneron
Buy$95.5B45.26%19.7685.77%0.40%

Analyst Recommendation on KALVISTA PHARMACEUTICALS INC Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for KALVISTA PHARMACEUTICALS INC. Average target price of $28.6

KALVISTA PHARMACEUTICALS INC Share Price Target

Get share price movements and forecasts by analysts on KALVISTA PHARMACEUTICALS INC.

What analysts predicted

5.59%UPSIDE

Target Price

$28.6

Current Price

$27

Analyzed by

12 Analysts

Target

$28.60

KALVISTA PHARMACEUTICALS INC target price $28.6, a slight upside of 5.59% compared to current price of $27. According to 12 analysts rating.

KALVISTA PHARMACEUTICALS INC Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Total Revenue
-
1
-
-
-
-
1
40
40
59
Gross Profit
0
-25
0
-
-
-15
0
37
37
55
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-29
-44
-40
-42
-48
-52
-60
-23
-23
-5
Net Profit Margin
0.00%
-3702.24%
0.00%
0.00%
0.00%
0.00%
-4214.31%
-57.48%
-57.48%
-8.96%

KALVISTA PHARMACEUTICALS INC Annual Profit & Loss

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Total Revenue
1
8
16
12
12
-
-
-
-
73
Gross Profit
1
8
16
-27
-41
0
0
-86
0
67
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-15
-20
-29
-46
-82
-92
-126
-183
-164
Net Profit Margin
-1236.90%
-188.29%
-129.08%
-229.44%
-364.41%
0.00%
0.00%
0.00%
0.00%
-223.16%

Global Institutional Holdings in KALVISTA PHARMACEUTICALS INC

Check out the Institutions with significant holdings in KALVISTA PHARMACEUTICALS INC.

Funds
Holdings
Bank of America Corp
0.73%
Millennium Management LLC
3.59%
Geode Capital Management, LLC
1.87%
Woodline Partners LP
2.84%
Octagon Capital Advisors LP
2.72%
See all

KALVISTA PHARMACEUTICALS INC News & Key Events

  • img

    Today's Timeline - 12 September

    Fri, 06:16 PM

    -

    Analyst Andrew Fein maintains Buy rating on KalVista, citing strong early launch metrics for Ekterly and a price target of $27.

Insights on KALVISTA PHARMACEUTICALS INC

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, KALV has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, KALV stock has moved up by 59.4%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, KALV has outperformed top 5 stocks with highest market-cap in its industry

About KALVISTA PHARMACEUTICALS INC

KalVista Pharmaceuticals, Inc. is a global pharmaceutical company. It has discovered and developed EKTERLY, an oral on-demand treatment for hereditary angioedema (HAE). EKTERLY is formulated as a film-coated tablet for oral administration, with high bioavailability and selectivity for plasma kallikrein, enabling maximal dosing and a rapid decline in edema effectors that cause swelling during an HAE attack. Its clinical trials include KONFIDENT-KID, KONFIDENT-S and KONFIDENT. KONFIDENT-KID is an open-label clinical trial of sebetralstat for on-demand treatment of HAE attacks in pediatric patients. KONFIDENT-KID collects safety, pharmacokinetic and efficacy data for each patient for up to one year and features a proprietary pediatric orally disintegrating tablet formulation of sebetralstat. KONFIDENT-S study is an open-label extension trial to evaluate the long-term safety of sebetralstat for on-demand treatment of HAE attacks in adolescent and adult patients with type I or type II HAE.
OrganisationKALVISTA PHARMACEUTICALS INC

FAQs

What is KALVISTA PHARMACEUTICALS INC share price today?

KALVISTA PHARMACEUTICALS INC share price today is $27.00 as on at the close of the market. KALVISTA PHARMACEUTICALS INC share today touched a day high of $27.00 and a low of $26.98.

What is the 52 week high and 52 week low for KALVISTA PHARMACEUTICALS INC share?

KALVISTA PHARMACEUTICALS INC share touched a 52 week high of $27.00 on and a 52 week low of $10.41 on . KALVISTA PHARMACEUTICALS INC stock price today i.e. is closed at $27.00,which is 0.00% down from its 52 week high and 159.37% up from its 52 week low.

How to invest in KALVISTA PHARMACEUTICALS INC Stock (KALV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for KALVISTA PHARMACEUTICALS INC on INDmoney app. Click on Buy button.

What is the minimum amount required to buy KALVISTA PHARMACEUTICALS INC Stock (KALV) from India?

Indian investors can start investing in KALVISTA PHARMACEUTICALS INC (KALV) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in KALVISTA PHARMACEUTICALS INC stock (as per the Rupee-Dollar exchange rate as on ). Based on KALVISTA PHARMACEUTICALS INC share’s latest price of $27.00 as on June 11, 2026 at 8:46 am IST, you will get 0.3704 shares of KALVISTA PHARMACEUTICALS INC. Learn more about fractional shares .